绝经前自然杀手细胞功能障碍BRCA1突变载体:卵巢癌发生的潜在机制
Shaun Haran1,2, Kantaraja Chindera1, May Sabry3
1Department of Women's Cancer, Elizabeth Garrett Anderson (EGA) Institute for Women's Health, University College London (UCL), 72 Huntley Street, London WC1E 6DD, UK.
Cancers
|March 28, 2024
概括
携带BRCA1突变的携带者表现出改变的自然杀手 (NK) 细胞功能,特别是在特定的卵巢周期阶段. 输卵管中的这种受损的免疫监测可能会促进早期卵巢癌的发展.
科学领域:
- 妇科瘤学 妇科瘤学
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 在BRCA1突变载体中,卵管卵巢癌发生的组织特异性因素尚不清楚.
- 生殖系BRCA1突变会影响由CD3-CD56+自然杀手 (NK) 细胞进行的癌症免疫监测.
研究的目的:
- 调查生殖线BRCA1突变对输卵管内NK细胞功能的细胞自主和细胞非自主影响.
- 评估孕激素和缺氧对BRCA1载体NK细胞活性的影响.
主要方法:
- 在绝经前的BRCA1突变携带者和非携带者进行比较.
- 分析了尿中的孕代谢物和NK细胞对瘤点的细胞毒性.
- 在输卵管组织中检查了缺氧诱导因子1-alpha (HIF-1α).
- 研究了孕激素和缺氧对NK细胞功能的影响,以卵巢阶段特定的方式.
主要成果:
- BRCA1 携带者表现出改变的孕激素代谢和减少的外周NK细胞活性,因卵巢阶段而异.
- 孕激素以剂量依赖的方式降低了NK细胞的细胞毒性,使用米费普里斯可逆.
- 腹输卵管显示HIF-1α较高,表明缺氧位,特别是在BRCA1载体中.
- 缺氧进一步降低了高风险载体的瘤细胞毒性.
结论:
- 在BRCA1载体中,特定阶段的NK细胞活性变化可能会促进特定部位的前入侵性癌症发生.
- 高风险携带者在整个生殖寿命中的累积影响可能会导致卵巢癌风险.
- 这些发现支持了作为一种降低风险策略的排卵抑制的流行病学证据.
相关概念视频
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K


